Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.06 CAD
Change Today +0.005 / 10.00%
Volume 200.0K
VPT On Other Exchanges
Symbol
Exchange
OTC US
As of 3:40 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

ventripoint diagnostics ltd (VPT) Snapshot

Open
C$0.05
Previous Close
C$0.05
Day High
C$0.06
Day Low
C$0.05
52 Week High
05/27/14 - C$0.11
52 Week Low
12/9/14 - C$0.04
Market Cap
10.3M
Average Volume 10 Days
140.7K
EPS TTM
C$-0.0031
Shares Outstanding
186.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VENTRIPOINT DIAGNOSTICS LTD (VPT)

Related News

No related news articles were found.

ventripoint diagnostics ltd (VPT) Related Businessweek News

No Related Businessweek News Found

ventripoint diagnostics ltd (VPT) Details

VentriPoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company offers Ventripoint Medical System that is used to generate critical volume and functional measurements of the right ventricle. VentriPoint Diagnostics Ltd. is based in Bellevue, Washington.

ventripoint diagnostics ltd (VPT) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $247.9K
Chief Financial Officer
Total Annual Compensation: $72.6K
Compensation as of Fiscal Year 2013.

ventripoint diagnostics ltd (VPT) Key Developments

Ventripoint Diagnostics Ltd. Appoints PVP Enterprises LLC as Exclusive Distributor to US Military Hospitals Including VA Hospitals

Ventripoint Diagnostics Ltd. announced that is has appointed PYP Enterprises LLC (PYP) to be the exclusive distributor to the US military hospitals including the VA hospitals.

VentriPoint Diagnostics Ltd. Announces Resignation of Brad Harlow as Director

VentriPoint Diagnostics Ltd. announced that Mr. Brad Harlow has resigned from the Board of Directors of the company to focus on his duties as CEO of Cardiac Insight Inc. He is also continuing as President & CEO of PhysioSonics Inc.

Ventripoint Applies to U.S. FDA to Expand Use of VMS Heart Analysis System to All Types of Heart Disease

Ventripoint Diagnostics Ltd. announced that it has recently filed an additional submission for 510(k) clearance to the U.S. Food & Drug Administration (FDA). The submission will involve a review process of up to 90 days from the date of acceptance by the US FDA. Clearance by the U.S. FDA will greatly increase the utility and market adoption of the Ventripoint Medical System (VMS(TM)).

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VPT:CN C$0.06 CAD +0.005

VPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VPT.
View Industry Companies
 

Industry Analysis

VPT

Industry Average

Valuation VPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 67.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 60.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENTRIPOINT DIAGNOSTICS LTD, please visit www.ventripoint.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.